Does TREPROSTINIL Cause Hepatic cancer? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Hepatic cancer have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
34
Reports of Hepatic cancer with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
11
Deaths
17
Hospitalizations
How Dangerous Is Hepatic cancer From TREPROSTINIL?
Of the 34 reports, 11 (32.4%) resulted in death, 17 (50.0%) required hospitalization.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
ADALIMUMAB (193)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
Which TREPROSTINIL Alternatives Have Lower Hepatic cancer Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE